Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jessica Mester

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN|September 14, 2013
A time study of cancer genetic counselors using a genetic counselor-only patient care model versus a traditional combined genetic counselor plus medical geneticist care modelBrandie Heald, Shanna Gustafson, Jessica Mester, et al.
Surgery|November 20, 2012
Should patients with Cowden syndrome undergo prophylactic thyroidectomy?Mira Milas, Jessica Mester, Rosemarie Metzger, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|March 9, 2013
Cognitive characteristics of PTEN hamartoma tumor syndromesRobyn M Busch, Jessica S Chapin, Jessica Mester, et al.
Human Molecular Genetics|October 8, 2011
Germline SDHx variants modify breast and thyroid cancer risks in Cowden and Cowden-like syndrome via FAD/NAD-dependant destabilization of p53Ying Ni, Xin He, Jinlian Chen, et al.
Cancer Genetics|September 23, 2020
Genotype-phenotype correlations among TP53 carriers: Literature review and analysis of probands undergoing multi-gene panel testing and single-gene testingCristina Fortuno, Tina Pesaran, Jessica Mester, et al.
Human Molecular Genetics|December 25, 2016
Germline compound heterozygous poly-glutamine deletion in USF3 may be involved in predisposition to heritable and sporadic epithelial thyroid carcinomaYing Ni, Spencer Seballos, Benjamin Fletcher, et al.
American Journal of Human Genetics|January 4, 2011
A clinical scoring system for selection of patients for PTEN mutation testing is proposed on the basis of a prospective study of 3042 probandsMin-Han Tan, Jessica Mester, Charissa Peterson, et al.
NPJ Genomic Medicine|December 22, 2017
Assessment of clinical workload for general and specialty genetic counsellors at an academic medical center: a tool for evaluating genetic counselling practicesBrandie Heald, Lisa Rybicki, Diane Clements, et al.
Human Mutation|June 3, 2020
Suggested application of HER2+ breast tumor phenotype for germline TP53 variant classification within ACMG/AMP guidelinesCristina Fortuno, Jessica Mester, Tina Pesaran, et al.
Human Mutation|December 10, 2020
Specifications of the ACMG/AMP variant interpretation guidelines for germline TP53 variantsCristina Fortuno, Kristy Lee, Magali Olivier, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Journal of the National Comprehensive Cancer Network : JNCCN|September 14, 2013
A time study of cancer genetic counselors using a genetic counselor-only patient care model versus a traditional combined genetic counselor plus medical geneticist care modelBrandie Heald, Shanna Gustafson, Jessica Mester, et al.
Surgery|November 20, 2012
Should patients with Cowden syndrome undergo prophylactic thyroidectomy?Mira Milas, Jessica Mester, Rosemarie Metzger, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|March 9, 2013
Cognitive characteristics of PTEN hamartoma tumor syndromesRobyn M Busch, Jessica S Chapin, Jessica Mester, et al.
Human Molecular Genetics|October 8, 2011
Germline SDHx variants modify breast and thyroid cancer risks in Cowden and Cowden-like syndrome via FAD/NAD-dependant destabilization of p53Ying Ni, Xin He, Jinlian Chen, et al.
Cancer Genetics|September 23, 2020
Genotype-phenotype correlations among TP53 carriers: Literature review and analysis of probands undergoing multi-gene panel testing and single-gene testingCristina Fortuno, Tina Pesaran, Jessica Mester, et al.
Human Molecular Genetics|December 25, 2016
Germline compound heterozygous poly-glutamine deletion in USF3 may be involved in predisposition to heritable and sporadic epithelial thyroid carcinomaYing Ni, Spencer Seballos, Benjamin Fletcher, et al.
American Journal of Human Genetics|January 4, 2011
A clinical scoring system for selection of patients for PTEN mutation testing is proposed on the basis of a prospective study of 3042 probandsMin-Han Tan, Jessica Mester, Charissa Peterson, et al.
NPJ Genomic Medicine|December 22, 2017
Assessment of clinical workload for general and specialty genetic counsellors at an academic medical center: a tool for evaluating genetic counselling practicesBrandie Heald, Lisa Rybicki, Diane Clements, et al.
Human Mutation|June 3, 2020
Suggested application of HER2+ breast tumor phenotype for germline TP53 variant classification within ACMG/AMP guidelinesCristina Fortuno, Jessica Mester, Tina Pesaran, et al.
Human Mutation|December 10, 2020
Specifications of the ACMG/AMP variant interpretation guidelines for germline TP53 variantsCristina Fortuno, Kristy Lee, Magali Olivier, et al.
Pageof 3